Ocuphire Pharma Stock Price on November 3, 2020

OCUP Stock  USD 1.51  0.15  9.04%   
Below is the normalized historical share price chart for Ocuphire Pharma extending back to November 30, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ocuphire Pharma stands at 1.51, as last reported on the 23rd of April, with the highest price reaching 1.64 and the lowest price hitting 1.50 during the day.
IPO Date
23rd of May 2005
200 Day MA
3.0671
50 Day MA
2.1744
Beta
0.242
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Ocuphire Stock, it is important to understand the factors that can impact its price. Ocuphire Pharma maintains Sharpe Ratio (i.e., Efficiency) of -0.18, which implies the firm had a -0.18% return per unit of risk over the last 3 months. Ocuphire Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ocuphire Pharma's Risk Adjusted Performance of (0.10), coefficient of variation of (544.03), and Variance of 15.03 to confirm the risk estimate we provide.
  
At this time, Ocuphire Pharma's Total Stockholder Equity is relatively stable compared to the past year. As of 04/23/2024, Liabilities And Stockholders Equity is likely to grow to about 56.6 M, while Common Stock is likely to drop 1,710. . As of 04/23/2024, Price Earnings To Growth Ratio is likely to grow to 0.05, while Price To Sales Ratio is likely to drop 3.24. Ocuphire Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1752

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsOCUP

Estimated Market Risk

 4.0
  actual daily
35
65% of assets are more volatile

Expected Return

 -0.7
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.18
  actual daily
0
Most of other assets perform better
Based on monthly moving average Ocuphire Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ocuphire Pharma by adding Ocuphire Pharma to a well-diversified portfolio.
Price Book
0.9149
Enterprise Value Ebitda
(2.66)
Price Sales
2.3968
Shares Float
23.8 M
Wall Street Target Price
19.2

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Ocuphire Pharma Stock history

Ocuphire Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ocuphire is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ocuphire Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ocuphire Pharma stock prices may prove useful in developing a viable investing in Ocuphire Pharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding21.6 M20.5 M
Net Income Applicable To Common Shares16.1 M16.9 M

Ocuphire Pharma Quarterly Net Working Capital

49.91 Million

Ocuphire Pharma Stock Technical Analysis

Ocuphire Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Ocuphire Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ocuphire Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Ocuphire Pharma Period Price Range

Ocuphire Pharma April 23, 2024 Market Strength

Market strength indicators help investors to evaluate how Ocuphire Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ocuphire Pharma shares will generate the highest return on investment. By undertsting and applying Ocuphire Pharma stock market strength indicators, traders can identify Ocuphire Pharma entry and exit signals to maximize returns

Ocuphire Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Ocuphire Pharma's price direction in advance. Along with the technical and fundamental analysis of Ocuphire Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ocuphire to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Ocuphire Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Ocuphire Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ocuphire Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Ocuphire Pharma Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocuphire Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
To learn how to invest in Ocuphire Stock, please use our How to Invest in Ocuphire Pharma guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Ocuphire Stock analysis

When running Ocuphire Pharma's price analysis, check to measure Ocuphire Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocuphire Pharma is operating at the current time. Most of Ocuphire Pharma's value examination focuses on studying past and present price action to predict the probability of Ocuphire Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocuphire Pharma's price. Additionally, you may evaluate how the addition of Ocuphire Pharma to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Ocuphire Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocuphire Pharma. If investors know Ocuphire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocuphire Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.46)
Revenue Per Share
0.882
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.13)
Return On Equity
(0.21)
The market value of Ocuphire Pharma is measured differently than its book value, which is the value of Ocuphire that is recorded on the company's balance sheet. Investors also form their own opinion of Ocuphire Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ocuphire Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocuphire Pharma's market value can be influenced by many factors that don't directly affect Ocuphire Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocuphire Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocuphire Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocuphire Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.